Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.
Dysregulation of PKCε is involved in several serious diseases such as cancer, type II diabetes and Alzheimer's disease. Therefore, specific activators and inhibitors of PKCε hold promise as future therapeutics, in addition to being useful in research into PKCε regulated pathways. We have previo...
Guardado en:
Autores principales: | Milla Summanen, Niko Granqvist, Raimo K Tuominen, Marjo Yliperttula, C Theo Verrips, Johannes Boonstra, Christophe Blanchetot, Elina Ekokoski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b60389161564e70bffc909754728330 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PKCε phosphorylates MIIP and promotes colorectal cancer metastasis through inhibition of RelA deacetylation
por: Tao Chen, et al.
Publicado: (2017) -
A genetically-encoded crosslinker screen identifies SERBP1 as a PKCε substrate influencing translation and cell division
por: Silvia Martini, et al.
Publicado: (2021) -
Dataset of bond enthalpies (εAA, εAB, εBB) in 975 binary intermetallic compounds
por: Daniel Miracle, et al.
Publicado: (2021) -
PKCα diffusion and translocation are independent of an intact cytoskeleton
por: Xin Hui, et al.
Publicado: (2017) -
Overexpressed PKCδ downregulates the expression of PKCα in B16F10 melanoma: induction of apoptosis by PKCδ via ceramide generation.
por: Kuntal Halder, et al.
Publicado: (2014)